<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04910984</url>
  </required_header>
  <id_info>
    <org_study_id>2000027864</org_study_id>
    <secondary_id>1R21AI152927-01A1</secondary_id>
    <nct_id>NCT04910984</nct_id>
  </id_info>
  <brief_title>Developing a Chatbot to Promote HIV Testing</brief_title>
  <official_title>Developing an Artificial Intelligence Chatbot to Promote HIV Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the feasibility of a Chatbot in promoting HIV testing in a pilot RCT with 80&#xD;
      men who have sex with men in Kuala Lumpur, Malaysia will be studied. Participants will be&#xD;
      randomized to Chatbot or treatment as usual (TAU) groups. Participants in the intervention&#xD;
      group will receive automated personalized messages containing HIV testing-related&#xD;
      information, motivation and skills.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After informed consent, participants will be randomly assigned to Chatbot or TAU groups using&#xD;
      stratified randomization by age. Participants in TAU will receive attention-matched&#xD;
      educational materials manually sent by the research assistant. Participants in the&#xD;
      intervention group will receive an automated personalized question message (root-node&#xD;
      message) from the Chabot. In each round of the interactive communication, the Chatbot will&#xD;
      provide automated personalized messages containing HIV testing-related information,&#xD;
      motivation and skills based on participants' answers and will continuously update over time.&#xD;
      Participants will be observed over 180 days with responses and interactions stored on a&#xD;
      HIPAA-compliant and protected cloud. An independent assessment of recent testing and reasons&#xD;
      why will be sent by link to both TAU and intervention groups using a link to a Qualtrics&#xD;
      survey housed on REDCap at baseline and after 90 and 180 days. After 180 days, the RA will&#xD;
      send an additional REDCap survey to intervention participants to assess the feasibility of&#xD;
      the Chabot to measure 4 key elements: acceptability, practicality, demand, and adaptation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HIV testing</measure>
    <time_frame>30 days, 60 days, 90 days, 120 days, 150 days, and 180 days</time_frame>
    <description>The efficacy of the Chatbot versus TAU with HIV testing as the primary outcome will be measured. The primacy efficacy outcome is the proportion of MSM who get tested within 180 days. This will be measured every 30 days by asking if MSM tested for HIV in the past 30 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>180 days</time_frame>
    <description>The number of participants contacted divided by the number of participants who signed the consent form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completion rate</measure>
    <time_frame>180 days</time_frame>
    <description>The number of participants who signed the consent form divided by the number of participants who completed the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interaction time</measure>
    <time_frame>180 days</time_frame>
    <description>The time of the interaction between participants and Chatbot</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interaction frequency</measure>
    <time_frame>180 days</time_frame>
    <description>The frequency of the interaction between participants and Chatbot</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Chatbot group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Chatbot messages</intervention_name>
    <description>Automated personalized messages containing HIV testing-related information, motivation and skills</description>
    <arm_group_label>Chatbot group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention-matched educational materials</intervention_name>
    <description>Attention-matched educational materials manually sent by our research assistant. These educational materials will be retrieved from CDC and WHO websites and curated into short articles (&lt;200 words) and pictures. All educational materials will be screened by HIV experts from University of Malaya to ensure accuracy before being sent to participants.</description>
    <arm_group_label>TAU group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  cis-gender male&#xD;
&#xD;
          -  18+ years;&#xD;
&#xD;
          -  had condomless sex with men in the past 6 months&#xD;
&#xD;
          -  has a smartphone&#xD;
&#xD;
          -  speaks Bahasa Malay or English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not able to read Malay or English&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey A. Wickersham, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Malaya</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Jalan Pantai Baharu</state>
        <zip>59990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Rumana Akhter Saifi, PhD</last_name>
      <phone>22463383</phone>
      <phone_ext>603</phone_ext>
      <email>rumanasaifi@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>May 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV testing</keyword>
  <keyword>PrEp</keyword>
  <keyword>HIV care</keyword>
  <keyword>Chatbot</keyword>
  <keyword>MSM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

